Additional information
Off white Powder
2417155-08-7
ACI-020215
58.3-61.3°C
C25H37NO5
431.56
Ambient
2-8°C
Antihypertensive
Pharmaceutical Impurity Standards
(2RS)-1-[4-((4-((2-isopropoxyethoxy)methyl) phenoxy)methyl)phenoxy]-3-(isopropylamino)-2-propanol
(2RS)-1-[4-((4-((2-isopropoxyethoxy)methyl)phenoxy)methyl)phenoxy]-3-(isopropylamino)-2-propanol
2-Propanol, 1-[4-[[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]






![Ethyl (3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethylsulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate](https://staging.analyticachemie.in/wp-content/uploads/1A06130-150x150.png)


![2-sec-butyl-4-{4-[4-(4-methoxyphenyl)piperazin-1-yl]phenyl}-2H-1,2,4-triazol-3(4H)-one](https://staging.analyticachemie.in/wp-content/uploads/1A06380-150x110.png)
![Abiraterone Isopropyl Ether (25 mg) (3-((3S,8R,9S,10R,13S,14S)-3-isopropoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine; 3beta-Isopropoxy-17-(pyridin-3-yl)androsta-5,16-diene)](https://staging.analyticachemie.in/wp-content/uploads/image-1-150x145.png)